The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine ...

A new study from US scientists has predicted a huge increase in this killer cancer-and there's one group in particular at ...

Uterine cancer incidence and mortality rates are projected to increase significantly over the next three decades in the ...

A new study from US scientists has predicted a huge increase in this killer cancer-and there's one group in particular at ...

Uterine cancer rates in the United States are expected to climb significantly over the next 25 years, with Black women ...

Endometrial cancer that is recurrent or diagnosed in advanced stages has a median overall survival of up to 30 months. 1 While there have been recent treatment advances, there is still a need to ...

With a median follow-up of 36.6 months for the laparoscopy group and 29.6 months for the laparotomy group, they reported 5-year overall survival rates of 99.2 and 97%, respectively.

Drs Ursula A. Matulonis and Leif W. Ellisen discuss endometrial cancer and ADCs, including resistance mechanisms, ADC sequencing, what's exciting in the field, and novel payloads.

Group C: CRC diagnosed after another cancer (16.3%) Key findings: Best survival: Group B (CRC first) had the highest overall survival (50.4 months) and cancer-specific survival (51.3 months).